Picture of McKesson logo

MCK McKesson Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareBalancedLarge CapSuper Stock

Annual cashflow statement for McKesson, fiscal year end - March 31st, USD millions except per share, conversion factor applied.

2022
March 31st
2023
March 31st
2024
March 31st
2025
March 31st
2026
March 31st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line1,2873,7223,1603,4815,099
Depreciation
Amortisation
Deferred Taxes
Non-Cash Items1,7318791,1491,204-65
Discontinued Operations
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital82440-27874162
Change in Accounts Receivable
Change in Inventories
Change in Accounts Payable
Change in Accrued Expenses
Change in Taxes Payable
Change in Other Liabilities
Net Change in Other Assets & Liabilities
Cash from Operating Activities3,8945,6294,3146,0856,155
Capital Expenditures-535-558-687-859-745
Purchase of Fixed Assets
Software Development Costs
Other Investing Cash Flow Items44616-385126-2,687
Acquisition of Business
Sale of Business
Other Investing Cash Flow
Cash from Investing Activities-89-542-1,072-733-3,432
Financing Cash Flow Items-1,414-324-175-554-372
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-6,321-4,368-3,342-3,965-4,631
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash-2,461744-941,371-1,888